{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:23:04Z","timestamp":1762842184944,"version":"build-2065373602"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,20]],"date-time":"2021-10-20T00:00:00Z","timestamp":1634688000000},"content-version":"vor","delay-in-days":292,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Treatment and Research Communications"],"published-print":{"date-parts":[[2021]]},"DOI":"10.1016\/j.ctarc.2021.100481","type":"journal-article","created":{"date-parts":[[2021,10,22]],"date-time":"2021-10-22T04:57:31Z","timestamp":1634878651000},"page":"100481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Stereotactic body radiation therapy (SBRT) for patients with oligometastatic\/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study."],"prefix":"10.1016","volume":"29","author":[{"given":"Giuseppe","family":"Facondo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gianluca","family":"Vullo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"Valeriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Ascolese","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vitaliana","family":"De Sanctis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mattia Falchetto","family":"Osti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ctarc.2021.100481_bib0001","doi-asserted-by":"crossref","first-page":"S223","DOI":"10.21037\/gs.2019.06.02","article-title":"Magnetic resonance imaging of adrenal gland: state of the art","author":"D'Amuri","year":"2019","journal-title":"Gland Surg."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100481_bib0002","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1046\/j.0300-0664.2001.01435.x","article-title":"Metastatic tumours of the adrenal glands: a 30-year experience in a teaching hospital","volume":"56","author":"Lam","year":"2002","journal-title":"Clin. Endocrinol. (Oxf)"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100481_bib0003","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1148\/radiographics.21.4.g01jl21995","article-title":"State-of-the-art adrenal imaging","volume":"21","author":"Mayo-Smith","year":"2001","journal-title":"Radiographics"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100481_bib0004","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/1097-0142(197702)39:2<547::AID-CNCR2820390225>3.0.CO;2-9","article-title":"Randomized sequential hormonal therapy vs adrenalectomy for metastatic breast carcinoma","volume":"39","author":"Yonemoto","year":"1977","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.ctarc.2021.100481_bib0005","first-page":"127","article-title":"The role of resection in the management of melanoma metastatic to the adrenal gland","volume":"109","author":"Branum","year":"1991","journal-title":"Surgery"},{"issue":"6","key":"10.1016\/j.ctarc.2021.100481_bib0006","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0003-4975(96)00611-X","article-title":"Does resection of adrenal metastases from non-small cell lung cancer improve survival?","volume":"62","author":"Luketich","year":"1996","journal-title":"Ann. Thorac. Surg."},{"issue":"4","key":"10.1016\/j.ctarc.2021.100481_bib0007","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/bjs.1800830432","article-title":"Adrenalectomy for metastatic disease to the adrenal glands","volume":"83","author":"Lo","year":"1996","journal-title":"Br. J. Surg."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100481_bib0008","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.surg.2013.06.021","article-title":"Adrenalectomy for solid tumor metastases: results of a multicenter European study","volume":"154","author":"Moreno","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/j.ctarc.2021.100481_bib0009","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1002\/1097-0142(19900315)65:6<1318::AID-CNCR2820650611>3.0.CO;2-H","article-title":"Palliative Radiotherapy for Symptomatic Adrenal Metastases","volume":"65","author":"Soffen","year":"1990","journal-title":"Cancer"},{"issue":"23","key":"10.1016\/j.ctarc.2021.100481_bib0010","doi-asserted-by":"crossref","first-page":"5198","DOI":"10.1158\/1078-0432.CCR-15-0822","article-title":"New strategies in stereotactic radiotherapy for oligometastases","volume":"21","author":"DA","year":"2015","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.ctarc.2021.100481_bib0011","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.rpor.2015.05.009","article-title":"SBRT: a viable option for treating adrenal gland metastases","volume":"20","author":"Ippolito","year":"2015","journal-title":"Rep. Pract. Oncol. Radiother."},{"issue":"2","key":"10.1016\/j.ctarc.2021.100481_bib0012","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"issue":"5","key":"10.1016\/j.ctarc.2021.100481_bib0013","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the radiation therapy oncology group (RTOG) and the European organization for research and treatment of cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100481_bib0014","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/0360-3016(95)00059-8","article-title":"Late Effects toxicity scoring: the SOMA scale","volume":"31","author":"Pavy","year":"1995","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"issue":"1","key":"10.1016\/j.ctarc.2021.100481_bib0015","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00066-013-0450-y","article-title":"Definition of stereotactic body radiotherapy: principles and practice for the treatment of stage I nonsmall cell lung cancer","volume":"190","author":"Guckenberger","year":"2014","journal-title":"StrahlentherOnkol"},{"key":"10.1016\/j.ctarc.2021.100481_bib0016","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.lungcan.2016.04.012","article-title":"Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-a pooled analysis of the German working group \u201cstereotactic radiotherapy","volume":"97","author":"Rieber","year":"2016","journal-title":"Lung Cancer"},{"issue":"8","key":"10.1016\/j.ctarc.2021.100481_bib0017","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1634\/theoncologist.2012-0092","article-title":"Review and uses of stereotactic body radiation therapy for oligometastases","volume":"17","author":"Alongi","year":"2012","journal-title":"Oncologist"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100481_bib0018","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.radonc.2008.03.013","article-title":"Real-time tumor-tracking radiotherapy for adrenal tumors","volume":"87","author":"Katoh","year":"2008","journal-title":"Radiother. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100481_bib0019","doi-asserted-by":"crossref","first-page":"618","DOI":"10.3109\/0284186X.2011.652738","article-title":"Long-term local control achieved after hypofractionated stereotactic body radiotherapy for adrenal gland metastases: a retrospective analysis of 34 patients","volume":"51","author":"Scorsetti","year":"2012","journal-title":"Acta. Oncol."},{"issue":"5","key":"10.1016\/j.ctarc.2021.100481_bib0020","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1007\/s10585-020-10052-0","article-title":"Adrenal SBRT: a multi-institutional review of treatment outcomes and toxicity","volume":"37","author":"Helis","year":"2020","journal-title":"ClinExp. Metastasis"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100481_bib0021","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1186\/s12885-020-07030-w","article-title":"Single-institutional outcome-analysis of low-dose stereotactic body radiation therapy (SBRT) of adrenal gland metastases","volume":"20","author":"Voglhuber","year":"2020","journal-title":"BMC Cancer"},{"issue":"4","key":"10.1016\/j.ctarc.2021.100481_bib0022","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.adro.2018.05.006","article-title":"Stereotactic body radiation therapy for adrenal gland metastases: outcomes and toxicity","volume":"3","author":"Toesca","year":"2018","journal-title":"Adv. Radiat. Oncol"},{"issue":"1","key":"10.1016\/j.ctarc.2021.100481_bib0023","first-page":"30","article-title":"Stereotactic body radiotherapy (SBRT) for adrenal metastases of oligometastatic or oligoprogressive tumor patients","volume":"15","author":"K\u00f6nig","year":"2020","journal-title":"RadiatOncol"},{"issue":"3","key":"10.1016\/j.ctarc.2021.100481_bib0024","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00066-018-1390-3","article-title":"Fractionated stereotactic radiation therapy for adrenal metastases: contributing to local tumor control with low toxicity","volume":"195","author":"Burjakow","year":"2019","journal-title":"StrahlentherOnkol"},{"key":"10.1016\/j.ctarc.2021.100481_bib0025","doi-asserted-by":"crossref","unstructured":"Scouarnec C., Pasquier D., Luu J., le Tinier F., Lebellec L., Rault E., et\u00a0al. Usefulness of Stereotactic Body Radiation Therapy for Treatment of Adrenal Gland Metastases. Front Oncol. 2019 Aug 7;9:732. doi: 10.3389\/fonc.2019.00732. PMID: 31448234; PMCID: PMC6692476.","DOI":"10.3389\/fonc.2019.00732"},{"issue":"9","key":"10.1016\/j.ctarc.2021.100481_bib0026","first-page":"5285","article-title":"Robot-assisted Extracranial Stereotactic Radiotherapy of Adrenal Metastases in Oligometastatic Non-small Cell Lung Cancer","volume":"37","author":"Celik","year":"2017","journal-title":"Anticancer Res."}],"container-title":["Cancer Treatment and Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468294221001775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T06:19:23Z","timestamp":1762841963000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468294221001775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"references-count":26,"alternative-id":["S2468294221001775"],"URL":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100481","relation":{},"ISSN":["2468-2942"],"issn-type":[{"type":"print","value":"2468-2942"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stereotactic body radiation therapy (SBRT) for patients with oligometastatic\/oligoprogressive adrenal metastases: Outcomes and toxicities profile in a monoinstitutional study.","name":"articletitle","label":"Article Title"},{"value":"Cancer Treatment and Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ctarc.2021.100481","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100481"}}